يعرض 1 - 10 نتائج من 25 نتيجة بحث عن '"Julie S. Larsen"', وقت الاستعلام: 1.04s تنقيح النتائج
  1. 1
    Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

    المؤلفون: Dingwei Ye, Katherine B. Bevans, Andrea J. Pereira de Santana Gomes, Sabine Brookman-May, Byung Ha Chung, Simon Chowdhury, Suneel Mundle, Álvaro Juárez, Ke Zhang, Kim N. Chi, Mustafa Ozguroglu, Anders Bjartell, Sharon Anne McCarthy, Julie S. Larsen, Neeraj Agarwal, Weili Sun, Robert Given, Nibedita Bandyopadhyay, Hirotsugu Uemura, Axel S. Merseburger

    المصدر: Journal of Clinical Oncology. 39:2294-2303

    مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Time Factors, 030232 urology & nephrology, Urology, law.invention, Double blind, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Androgen Receptor Antagonists, Humans, Medicine, Progression-free survival, Neoplasm Metastasis, Survival analysis, business.industry, Apalutamide, Interim analysis, Progression-Free Survival, Castration-sensitive prostate cancer, Clinical trial, Prostatic Neoplasms, Castration-Resistant, Thiohydantoins, Oncology, chemistry, 030220 oncology & carcinogenesis, Disease Progression, Quality of Life, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cff925b7e8aeb3a49455cb1d40f9ed4
    https://doi.org/10.1200/jco.20.03488

    أضف إلى المفضلة
  2. 2
    PD34-11 PROSTATE-SPECIFIC ANTIGEN KINETICS IN PATIENTS WITH ADVANCED PROSTATE CANCER TREATED WITH APALUTAMIDE: RESULTS FROM THE TITAN AND SPARTAN STUDIES

    المؤلفون: Eric J. Small, Fred Saad, Julie S. Larsen, Neeraj Agarwal, Suneel Mundle, Simon Chowdhury, Matthew R. Smith, Julie N. Graff, Stéphane Oudard, Gang Li, Angela Lopez-Gitlitz, Kim N. Chi, Sharon Anne McCarthy

    المصدر: Journal of Urology. 206

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Urology, Apalutamide, medicine.disease, Androgen deprivation therapy, chemistry.chemical_compound, Prostate cancer, Prostate-specific antigen, chemistry, Internal medicine, medicine, In patient, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4abd36bedfb965dc6f7c7e9c528329e3
    https://doi.org/10.1097/ju.0000000000002038.11

    View record from ScienceDirect
    أضف إلى المفضلة
  3. 3
    PD10-11 APALUTAMIDE FOR METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER IN TITAN: PROGNOSTIC IMPORTANCE OF PROSTATE-SPECIFIC ANTIGEN RESPONSES

    المؤلفون: Axel S. Merseburger, Suneel Mundle, Angela Lopez-Gitlitz, Anil Londhe, Anders Bjartell, Andrea J. Pereira de Santana Gomes, Álvaro Juárez Soto, Hirotsugu Uemura, Kim N. Chi, Robert Given, Simon Chowdhury, Julie S. Larsen, Mustafa Ozguroglu, Sharon Anne McCarthy, Neeraj Agarwal, Dingwei Ye, Byung Ha Chung

    المصدر: Journal of Urology. 203

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Urology, Apalutamide, Castration-sensitive prostate cancer, Androgen deprivation therapy, Prostate-specific antigen, chemistry.chemical_compound, chemistry, Internal medicine, medicine, Overall survival, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4395a93a67bd2fc653e8634e36329de0
    https://doi.org/10.1097/ju.0000000000000844.011

    View record from ScienceDirect
    أضف إلى المفضلة
  4. 4
    Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

    المؤلفون: Yishai Ofran, Julie S. Larsen, Steven Knapper, Marion Subklewe, Gail J. Roboz, Indrajeet Singh, Michael Heuser, Ho Jin Shin, Agnieszka Wierzbowska, Claude Eric Bulabois, Mehmet Ali Özcan, Liang Xiu, Jorge E. Cortes, Daniel A. Pollyea, Gert J. Ossenkoppele, Sergio Giralt, Uwe Platzbecker, Pau Montesinos, Stefan Deneberg, Fei Huang, Cristina Papayannidis, Andrew H. Wei, Su-Peng Yeh, Hartmut Döhner, Vadim Doronin

    المساهمون: CCA - Cancer Treatment and quality of life, Hematology laboratory

    المصدر: Leukemia
    Montesinos, P, Roboz, G J, Bulabois, C E, Subklewe, M, Platzbecker, U, Ofran, Y, Papayannidis, C, Wierzbowska, A, Shin, H J, Doronin, V, Deneberg, S, Yeh, S P, Ozcan, M A, Knapper, S, Cortes, J, Pollyea, D A, Ossenkoppele, G, Giralt, S, Döhner, H, Heuser, M, Xiu, L, Singh, I, Huang, F, Larsen, J S & Wei, A H 2021, ' Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy : results from a multicenter, randomized, phase 2/3 study ', Leukemia, vol. 35, no. 1, pp. 62-74 . https://doi.org/10.1038/s41375-020-0773-5
    r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
    instname
    Leukemia, 35(1), 62-74. Nature Publishing Group

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_treatment, Kaplan-Meier Estimate, RECOMMENDATIONS, law.invention, 0302 clinical medicine, Antineoplastic Agents, Immunological, Randomized controlled trial, AML, law, Antineoplastic Combined Chemotherapy Protocols, ACUTE MYELOGENOUS LEUKEMIA, Hazard ratio, Myeloid leukemia, Hematology, Middle Aged, Prognosis, Leukemia, Myeloid, Acute, Treatment Outcome, Research Design, 030220 oncology & carcinogenesis, ACID, Female, Drug Monitoring, medicine.drug, EXPRESSION, medicine.medical_specialty, Combination therapy, Decitabine, DIAGNOSIS, Antibodies, Monoclonal, Humanized, Article, 03 medical and health sciences, Internal medicine, medicine, MANAGEMENT, Humans, Aged, Chemotherapy, OLDER PATIENTS, business.industry, Odds ratio, Discontinuation, LOW-DOSE CYTARABINE, 030104 developmental biology, RECEPTOR-ALPHA CHAIN, business

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ffc80d49fb9dc9e35dcb946c3ebdf7
    https://europepmc.org/articles/PMC7787975/

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  5. 5
    Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study

    المؤلفون: Kris Deprince, Tomoyoshi Hatayama, Junya Aoyama, Hirotsugu Uemura, Kazuyoshi Iijima, Hiroji Uemura, Gaku Arai, Kim N. Chi, Jinhui Li, Julie S. Larsen, Sharon Anne McCarthy, Angela Lopez-Gitlitz, Koji Fujii, Hiroyoshi Suzuki, Kazuo Nishimura

    المصدر: International journal of urology : official journal of the Japanese Urological AssociationReferences. 28(3)

    مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Urology, Population, 030232 urology & nephrology, Subgroup analysis, Placebo, Androgen deprivation therapy, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Japan, Internal medicine, medicine, Humans, Castration, education, education.field_of_study, business.industry, Hazard ratio, Apalutamide, Androgen Antagonists, Interim analysis, medicine.disease, Prostatic Neoplasms, Castration-Resistant, chemistry, Thiohydantoins, 030220 oncology & carcinogenesis, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d098db41012d1b8df2fa4919d0bde2f
    https://pubmed.ncbi.nlm.nih.gov/33327040

    View record at Wiley
    أضف إلى المفضلة
  6. 6
    Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT)

    المؤلفون: Anders Bjartell, Weili Sun, Suneel Mundle, Spyros Triantos, Katherine B. Bevans, Ke Zhang, Mustafa Ozguroglu, Byung Ha Chung, Simon Chowdhury, Kim N. Chi, Sharon Anne McCarthy, Andrea J. Pereira de Santana Gomes, Robert Given, Axel S. Merseburger, Julie S. Larsen, Nibedita Bandyopadhyay, Hirotsugu Uemura, Neeraj Agarwal, Álvaro Juárez Soto, Dingwei Ye

    المصدر: Journal of Clinical Oncology. 39:11-11

    مصطلحات موضوعية: Prior treatment, Cancer Research, medicine.medical_specialty, business.industry, Apalutamide, Urology, Placebo, Castration-sensitive prostate cancer, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Oncology, chemistry, Docetaxel, 030220 oncology & carcinogenesis, Localized disease, medicine, In patient, business, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::48156a3a70142c349246ddb10a46fef9
    https://doi.org/10.1200/jco.2021.39.6_suppl.11

    أضف إلى المفضلة
  7. 7
    Abstract 776: Androgen receptor (AR) and non-AR aberrations associated with outcomes in metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) plus androgen deprivation therapy (ADT) in TITAN

    المؤلفون: Shibu Thomas, Felix Y. Feng, Neeraj Agarwal, Gerhardt Attard, Deborah Ricci, Simon Chowdhury, Alexander W. Wyatt, Angela Lopez-Gitlitz, Kim N. Chi, Julie S. Larsen, Michael Gormley, Dong Shen, Branko Miladinovic

    المصدر: Cancer Research. 80:776-776

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Prognostic variable, business.industry, Proportional hazards model, Apalutamide, Cancer, medicine.disease, Androgen receptor, Androgen deprivation therapy, chemistry.chemical_compound, Prostate cancer, symbols.namesake, chemistry, Internal medicine, medicine, symbols, business, Fisher's exact test

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8f2140b9fb7cba4b8ad9d6f9682cb235
    https://doi.org/10.1158/1538-7445.am2020-776

    أضف إلى المفضلة
  8. 8
    Molecular determinants of outcome for metastatic castration-sensitive prostate cancer (mCSPC) with addition of apalutamide (APA) or placebo (PBO) to androgen deprivation therapy (ADT) in TITAN

    المؤلفون: Alexander W. Wyatt, Angela Lopez-Gitlitz, Michael Gormley, Gerhardt Attard, Shibu Thomas, Clemente Aguilar-Bonavides, Kim N. Chi, Deborah Ricci, Felix Y. Feng, Neeraj Agarwal, Simon Chowdhury, Julie S. Larsen, Elai Davicioni

    المصدر: Journal of Clinical Oncology. 38:5535-5535

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Post hoc, business.industry, Apalutamide, Placebo, Castration-sensitive prostate cancer, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Internal medicine, Overall survival, medicine, In patient, business, 030215 immunology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::075e2ea572b13b97710edebe14e45c67
    https://doi.org/10.1200/jco.2020.38.15_suppl.5535

    أضف إلى المفضلة
  9. 9
    First results from TITAN: A phase III double-blind, randomized study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT)

    المؤلفون: Jinhui Li, Ke Zhang, Andrea J. Pereira de Santana Gomes, Margaret K. Yu, Anders Bjartell, Sharon Anne McCarthy, Kim N. Chi, Simon Chowdhury, Kris Deprince, V. Naini, Mustafa Ozguroglu, Robert Given, Hirotsugu Uemura, Julie S. Larsen, Neeraj Agarwal, Axel S. Merseburger, Dingwei Ye, Álvaro Juárez Soto, Shinta Cheng, Byung Ha Chung

    المصدر: Journal of Clinical Oncology. 37:5006-5006

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Apalutamide, Urology, Placebo, Castration-sensitive prostate cancer, law.invention, Double blind, Androgen deprivation therapy, Androgen receptor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Oncology, Randomized controlled trial, chemistry, law, 030220 oncology & carcinogenesis, medicine, In patient, business, 030215 immunology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6a72abbf74dae6019af9a870ecb5f5a9
    https://doi.org/10.1200/jco.2019.37.15_suppl.5006

    أضف إلى المفضلة
  10. 10
    Management of Allergic Rhinitisand Sinusitis

    المؤلفون: Kathryn V. Blake, Julie S. Larsen

    المصدر: Journal of Pharmacy Practice. 14:228-252

    مصطلحات موضوعية: medicine.medical_specialty, Health professionals, business.industry, Pharmacist, food and beverages, medicine.disease, 030226 pharmacology & pharmacy, Nasal saline, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, medicine, Pharmacology (medical), Nasal administration, Medical prescription, 030223 otorhinolaryngology, Airway, Intensive care medicine, business, Sinusitis

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1ea0c901df8d9e25d1a14c04c8efd9f1
    https://doi.org/10.1106/pwnx-t6xm-yqg2-hbnh

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء